Wednesday, March 25, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Analysis

Insider Sales and Strong Fundamentals: A Closer Look at MACOM’s Market Position

Dieter Jaworski by Dieter Jaworski
September 20, 2025
in Analysis, Insider Trading, Semiconductors
0
Macom Stock
0
SHARES
117
VIEWS
Share on FacebookShare on Twitter

MACOM Technology Solutions finds itself at an interesting juncture, with significant insider trading activity occurring alongside a backdrop of robust financial performance and continued analyst confidence. The company’s strategic focus on next-generation technologies further complicates the narrative for investors monitoring this semiconductor specialist.

Robust Quarterly Performance Sets a Strong Foundation

The company’s underlying business health appears solid, as demonstrated by its third-quarter fiscal 2025 results. MACOM reported a substantial 32.3% year-over-year revenue increase, reaching $252.1 million. On the profitability front, the company posted a GAAP net income of $36.5 million. Its adjusted earnings per share came in at $0.90, narrowly surpassing consensus estimates which had anticipated $0.89 per share.

Looking ahead, management has provided optimistic guidance for the fourth fiscal quarter. The revenue forecast is set between $256 million and $264 million. Similarly, adjusted earnings per share are projected to land in the range of $0.91 to $0.95, signaling expectations for continued sequential growth.

Significant Insider Transactions Draw Market Attention

Amidst this strong operational performance, noteworthy insider selling activity has captured investor interest. Susan Ocampo, a major shareholder, executed two substantial sales within days of each other. The first transaction occurred on September 15, involving the sale of 150,424 shares for approximately $19.92 million. This sale reduced her stake by 4.03% and was executed at an average price of $132.43 per share.

Just two days later, on September 17, Ocampo divested an additional 62,435 shares, generating roughly $8.3 million in proceeds. This secondary transaction, conducted at an average price of $133.02 per share, further decreased her holdings by 1.74%. Such concentrated selling by a key insider naturally prompts scrutiny from the investment community.

Should investors sell immediately? Or is it worth buying Macom?

Wall Street Maintains a Constructive Outlook

Despite the insider sales, analytical coverage remains largely positive. The consensus rating among Wall Street firms continues to be a “Moderate Buy.” A review of recommendations from ten covering firms reveals seven “Buy” ratings, one “Strong Buy” recommendation, and two advising investors to “Hold.”

Price targets reflect this cautious optimism:
* Average 12-month price target: $146.13
* High target: $160.00
* Low target: $115.00

Innovation as a Core Growth Driver

MACOM continues to distinguish itself through technological advancement, particularly in high-growth sectors like data centers and communications infrastructure. The company’s innovation pipeline remains active, evidenced by a recent announcement of a new chipset designed to enable PCIe and CXL connectivity over fiber optics, supporting ranges of up to 100 meters. This technology directly addresses critical needs in modern computing by reducing latency, lowering power consumption, and enhancing scalability.

The company is also set to showcase its expanding portfolio of RF, microwave, and millimeterwave products at the upcoming European Microwave Week in Utrecht. Key highlights for the event include:
* SATCOM Applications: Ka-band power amplifiers and low-noise amplifiers
* RFoF Solutions: A comprehensive transceiver portfolio supporting multiple frequency bands
* Radar Technologies: Ultra-low noise amplifiers tailored for E-band applications

This strategic focus on innovation and market engagement reinforces MACOM’s position as a leading supplier of high-performance semiconductor solutions across the telecommunications, industrial, defense, and data center markets.

Ad

Macom Stock: Buy or Sell?! New Macom Analysis from March 25 delivers the answer:

The latest Macom figures speak for themselves: Urgent action needed for Macom investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from March 25.

Macom: Buy or sell? Read more here...

Tags: Macom
Dieter Jaworski

Dieter Jaworski

About Dieter Jaworski From a numbers-obsessed child to creating his first investment newsletter. Even as a child, Dieter Jaworski's mother couldn't believe how fascinated he was with numbers. This early passion for mathematics and data analysis laid the foundation for a successful career in financial markets and investment analysis.
Areas of Expertise:
  • Quantitative Analysis
  • Financial Newsletter Publishing
  • Data-Driven Investment Strategies
  • Market Pattern Recognition
Dieter's unique approach combines his natural affinity for numbers with decades of market experience, providing investors with data-driven insights and practical investment strategies.

Related Posts

Oracle Stock
AI & Quantum Computing

Oracle’s Backlog Soars on Cloud and AI Contract Momentum

March 25, 2026
Ocugen Stock
Analysis

Ocugen Shares Tumble Despite Positive Clinical Trial Results

March 25, 2026
Coinbase Stock
Analysis

Regulatory Proposal Sparks Sell-Off in Coinbase Shares

March 25, 2026
Next Post
PPL Corp Stock

PPL Corp: A Dividend Powerhouse Faces Growth Challenges

Northern Stock

Strategic Moves: Northern Corporation Adjusts Rates and Expands Global Footprint

Equitrans Midstream Stock

EQT Reaps Massive Financial Rewards from Strategic Equitrans Acquisition

Recommended

Rocket Companies Stock

Rocket Companies Stock Surges on Fed Policy Speculation

7 months ago
Biopharmaceutical Markets and money (1)

Groundbreaking Preclinical Data on TN301 A Potential Breakthrough in Treating HFpEF

2 years ago
Airbnb Stock

Airbnb Faces Dual Challenges as Insiders Sell and Fee Structure Shifts

7 months ago
MSCI World ETF Stock

MSCI World ETF Reaches New Heights Amid Tech Sector Surge

6 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Bloom Energy Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Oracle Palantir PayPal Plug Power QuantumScape Realty Income Robinhood Rocket Lab USA Salesforce Strategy Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Regulatory Proposal Sparks Sell-Off in Coinbase Shares

UnitedHealth Faces Multifaceted Regulatory Scrutiny Ahead of Earnings

Intel’s Capital Reshuffle and Leadership Transition Revealed in Annual Filing

35,000 Guards for 359 Million Doors: The Cyber Deficit Wall Street Can No Longer Ignore

Palo Alto Networks Finalizes Debt Terms Following CyberArk Acquisition

Kuya Silver Shares Show Signs of Technical Recovery

Trending

Oracle Stock
AI & Quantum Computing

Oracle’s Backlog Soars on Cloud and AI Contract Momentum

by Jackson Burston
March 25, 2026
0

While much of the market's attention remains fixed on the developers of large AI models, Oracle has...

Alphabet Stock

Regulatory Scrutiny Looms Over Alphabet’s Aggressive AI Expansion

March 25, 2026
Ocugen Stock

Ocugen Shares Tumble Despite Positive Clinical Trial Results

March 25, 2026
Coinbase Stock

Regulatory Proposal Sparks Sell-Off in Coinbase Shares

March 25, 2026
Unitedhealth Stock

UnitedHealth Faces Multifaceted Regulatory Scrutiny Ahead of Earnings

March 25, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Oracle’s Backlog Soars on Cloud and AI Contract Momentum
  • Regulatory Scrutiny Looms Over Alphabet’s Aggressive AI Expansion
  • Ocugen Shares Tumble Despite Positive Clinical Trial Results

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com